BWM
MDCX

Base Wealth Management’s Medicus Pharma MDCX Stock Holding History

Base Wealth Management’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,543
Closed -$26.7K – 66
2025
Q3 		$26.7K Hold
11,543
– – 0.02% 63
2025
Q2 		$34.5K Hold
11,543
– – 0.02% 55
2025
Q1 		$42.9K Buy
+11,543
New +$36.2K 0.03% 52

Other funds holding MDCX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Base Wealth Management's MDCX Position: Q4 2025 in Review

Base Wealth Management sold out of Medicus Pharma (MDCX) in Q4 2025, closing a stake of 11,543 shares — an estimated $26.7K sold.

Base Wealth Management first reported a position in MDCX in Q1 2025 and held it in 3 quarters. The position peaked at $42.9K in Q1 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q4 2025.

  • Base Wealth Management reported no remaining Medicus Pharma position as of Q4 2025 after selling out during the quarter.
  • Base Wealth Management sold 11,543 Medicus Pharma shares in Q4 2025, an estimated $26.7K.
  • Base Wealth Management first reported a position in Medicus Pharma in Q1 2025 and held it in 3 quarters.
  • Base Wealth Management's Medicus Pharma position peaked at $42.9K in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q4 2025.

Based on Base Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.